| Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
| |
| Bandhan BSE Healthcare Index Fund (G) Direct |
| [Equity: Sectoral] |
|
| |
|
|
| Instruments Breakdown |
| Instruments |
Composition |
| Current Asset |
-0.20 |
| Equity |
100.03 |
| Trep |
0.17 |
|
| |
| Concentration Analysis |
| Top 5 Holdings |
39.78% |
| Top 10 Holdings |
57.19% |
| Top 25 Holdings |
78.76% |
|
|
|
| |
| Sector Analysis |
| Sector/Ratings |
Net Asset(%) |
| Pharma & Biotech |
77.06 |
| Healthcare |
22.97 |
| Cash |
-0.03 |
|
|
|
|
|
| Portfolio Metrics |
|
| PB Ratio |
6.37 |
| PE Ratio |
42.83 |
|
| |
| Top 25 Holdings |
|
|
| Holdings |
Net Asset(%) |
| Sun Pharmaceutical Industries Limited |
15.45 |
| Cipla Limited |
6.70 |
| Dr Reddys Laboratories Limited |
6.01 |
| Max Healthcare Institute Limited |
5.81 |
| DIVI LABORATORIES LTD |
5.81 |
| Apollo Hospitals Enterprise Limited |
5.41 |
| Lupin Limited |
4.09 |
| Aurobindo Pharma Limited |
3.04 |
| Fortis Health Care Ltd |
2.52 |
| Alkem Laboratories Limited |
2.35 |
| Torrent Pharmaceuticals Limited |
2.26 |
| Mankind Pharma Limited |
2.07 |
| Glenmark Pharmaceuticals Limited |
1.96 |
| Zydus Lifesciences Limited |
1.95 |
| IPCA Laboratories Limited |
1.65 |
| Laurus Labs Limited |
1.50 |
| Suven Pharmaceuticals Limited |
1.30 |
| Piramal Pharma Limited |
1.27 |
| Syngene International Limited |
1.21 |
| Abbott India Limited |
1.18 |
| Biocon Limited |
1.09 |
| J B Chemicals and Pharma Ltd |
1.08 |
| Krishna Inst of Medical Sciences Ltd. |
1.03 |
| Ajanta Pharma Limited |
1.01 |
| Gland Pharma Limited |
1.01 |
|
|
|
| |
|
| |
| Sector Analysis Graphical Mode |
|
| |
|
|
| |
|
 |
| |
|
|
|
